Healthcare: Is CVS Health's Anti-Tobacco Strategy Paying Off?

<p><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 16px;">CVS's plan to boost prescription revenue by abandoning Tobacco might be panning out, and Regeneron's pricey new drug could become a multibillion blockbuster.</span></p>